Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for plantar pain in epidermolysis bullosa simplex and pachyonychia congenita
2009-010763-17Phase 2Completed
- Sponsor
- Sophiahemmet
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in epidermolysis bullosa simplex (EBS) and pachyonychia congenita (PC) comparing Dysport with Placebo (2 arms). Primary endpoints: Plantar pain intensity and Quality of life. Started Mar 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
epidermolysis bullosa simplex (EBS)pachyonychia congenita (PC)
Beyond the preview
Go deeper on 2009-010763-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010763-17.